Ayrton Drug Manufacturing Ltd Announces Unaudited Earnings Results for the Period Ending June 30, 2018
Ayrton Drug Manufacturing Ltd. announced unaudited earnings results for the period ending June 30, 2018. For the period, the company reported revenue of GHS 36,218,331 against GHS 35,016,640 a year ago. Operating profit was GHS 7,152,754 against GHS 4,474,028 a year ago. Profit before tax was GHS 5,233,795 against GHS 3,267,919 a year ago. Profit after tax was GHS 3,615,319 against GHS 2,285,975 a year ago. Profit per share was GHS 0.0168 against GHS 0.0106 a year ago. Net cash flow from operating activities was GHS 1,770,725.13 against net cash flow used in operating activities of GHS 344,702.47 a year ago. Purchase of property, plant and equipment was GHS 645,768.99 against GHS 996,628.14 a year ago.